(Q46281641)

English

Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial

scientific article published in January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18778120

Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18778120

0 references

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18778120

author name string

Donald P Tashkin

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18778120

Stephen I Rennard

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18778120

Paula Martin

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18778120

Sulabha Ramachandran

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18778120

Ubaldo J Martin

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18778120

Mitchell Goldman

7

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18778120

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18778120

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18778120

68

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18778120

14

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18778120

1975-2000

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18778120

Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868140-00004

21 January 2018

Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868140-00004

21 January 2018

Standardization of Spirometry, 1994 Update. American Thoracic Society

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868140-00004

21 January 2018

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18778120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18778120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18778120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18778120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18778120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhaled corticosteroids and survival in chronic obstructive pulmonary disease: does the dose matter?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18778120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

St. George's Respiratory Questionnaire: MCID

1 reference

https://pubmed.ncbi.nlm.nih.gov/18778120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire

1 reference

https://pubmed.ncbi.nlm.nih.gov/18778120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18778120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18778120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reference spirometric values using techniques and equipment that meet ATS recommendations

1 reference

https://pubmed.ncbi.nlm.nih.gov/18778120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhaled steroids and outcomes in COPD: progressing beyond FEV1

1 reference

https://pubmed.ncbi.nlm.nih.gov/18778120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18778120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bridging the gap: using triangulation methodology to estimate minimal clinically important differences (MCIDs)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18778120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality in COPD: inevitable or preventable? Insights from the cardiovascular arena

1 reference

https://pubmed.ncbi.nlm.nih.gov/18778120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18778120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18778120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18778120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18778120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bronchodilation of formoterol administered with budesonide: device and formulation effects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18778120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of salmeterol xinafoate in the treatment of COPD

1 reference

https://pubmed.ncbi.nlm.nih.gov/18778120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18778120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide

1 reference

https://pubmed.ncbi.nlm.nih.gov/18778120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluating symptoms in chronic obstructive pulmonary disease: validation of the Breathlessness, Cough and Sputum Scale.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18778120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/18778120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18778120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-200868140-00004

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18778120

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18778120

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46281641&oldid=2207777015"